Doç. Dr. Muhammed Fatih Karakaya

Domaines d’intérêt médical indiqués par le médecin lui-même sur sa page du site de l’établissement. Source : medicana.com.tr.

Expérience

• 2013-2014Karabük Eğitim ve Araştırma Hastanesimedicana.com.tr
• 2017-2020Ankara Gülhane Eğitim ve Araştırma Hastanesimedicana.com.tr
• 2020-2023Ankara Üniversitesi Tıp Fakültesimedicana.com.tr
• 2023-2024Ankara Üniversitesi Tıp Fakültesimedicana.com.tr

Formation

• 2008İstanbul Üniversitesi Tıp Fakültesimedicana.com.tr
• 2013Gazi Üniversitesi Tıp Fakültesi İç Hastalıkları A.D. – İç hastalıkları ihtisasımedicana.com.tr
• 2017Ankara Üniversitesi Tıp Fakültesi Gastroenteroloji B.D. – Gastroenteroloji ihtisasımedicana.com.tr

• SpécialitéHépato-gastro-entérologiemedicana.com.trD’après la source
• ÉtablissementMedicana International Ankaramedicana.com.trD’après la source
• Publications68 publicationspage de profil sur medicana.com.trD’après la source
• Dernière synchronisation7 novembre 2026 03:06https://www.medicana.com.tr/hekim-detay/20963/muhammed-fatih-karakayamedicana.com.tr

1. KARAKAYA MUHAMMED FATİH, SOYKAN ARİF İRFAN (2022). UTILITY OF SERUM FERRITIN AS A PREDICTOR OF COLORECTAL CANCER IN ELDERLY PATIENTS. Abant Tip Dergisi, 11(1), 77-83., Doi: 10.47493/abantmedj.837087

   Source : page de profil sur medicana.com.tr

2. Karakaya F, Kalkan Ç, Karakaya M, Örmeci N. Rare But Life-Threatening Complication of Hydatid Disease Turkiye Parazitol Derg. 2017 Sep;41(3):180- 182. doi: 10.5152/tpd.2017.5078

   Source : page de profil sur medicana.com.tr

3. Idilman R, Karakaya F. Latest updates on chronic viral hepatitis B. Marmara Medical Journal 29 (2016): 33-37 d oi.org/10.5472/MMJsi.2901.07

   Source : page de profil sur medicana.com.tr

4. Duman S, Kuru D, Gumussoy M, Kiremitci S, Gokcan H, Ulas B, Ellik Z, Ozercan M, Er RE, Karakaya F, Bodakci E, Erden A, Elhan AH, Savas B, Loomba R, Idilman R A combination of non-invasive test sor the detection of significant fibrosis in patients with metabolic dysfunction-associated steatotic liver disease is not superior to magnetic resonance elastography alone Eur Radiol. 2023 Nov 21. doi: 10.1007/s00330-023-10441-5.

   Source : page de profil sur medicana.com.tr

5. KARAKAYA MUHAMMED FATİH, ER RAMAZAN ERDEM, KIRIMKER ELVAN ONUR, GÜMÜŞSOY MESUT, BODAKÇİ EMİN, ÖZERCAN ABDULLAH MÜBİN, DOĞANAY ERDOĞAN BEYZA, GÖKCAN HALE, KOLOĞLU MELTEM, KARAYALÇIN MEHMET KAAN, YURTAYDIN SÜLEYMAN CİHAN, TÜZÜNER ACAR, HAZİNEDAROĞLU SELÇUK MEVLÜT, ÇINAR KUBİLAY, ÖZKAN HASAN, İDİLMAN RAMAZAN (2023). Management of Biliary Complications in Liver Transplant Recipients with Duct-ToDuct Anastomosis: A Single-Center Experience. Turk J Gastroenterol. 34(2), 177- 181., Doi: 10.5152/tjg.2023.22724 2-

   Source : page de profil sur medicana.com.tr

6. Yurdaydin C, Keskin O, Yurdcu E, Çalişkan A, Önem S, Karakaya F, Kalkan Ç, Karatayli E, Karatayli S, Choong I, Apelian D, Koh C, Heller T, Idilman R, Bozdayi AM, Glenn JS. A phase 2 dose-finding study of lonafarnib and ritonavir with or without interferon alpha for chronic delta hepatitis. Hepatology. 2021 Dec 3. doi: 10.1002/hep.32259

   Source : page de profil sur medicana.com.tr

7. YILMAZ YUSUF, YILMAZ NİMET, ATEŞ FEHMİ, KARAKAYA MUHAMMED FATİH, GÖKCAN HALE, KAYA EDA, ADALI GUPSE, ÇALIŞKAN KARTAL AYSUN, ŞEN İLKER, AHISHALI EMEL, ÖZENİRLER MAYER SEREN, KORUK MEHMET, UYGUN AHMET, İDİLMAN RAMAZAN (2021). The Prevalence of Metabolic Associated Fatty Liver Disease in The Turkish Population: A Multicenter Study. Hepatol Forum. 2(2), 37-42., Doi: 10.14744/hf.2021.2020.0033

   Source : page de profil sur medicana.com.tr

8. KARAKAYA MUHAMMED FATİH, ÖZTEKİN ŞURA, ÖZTÜRK YELDA, KALKAN ÇAĞDAŞ, MELEKOĞLU ELLİK ZEYNEP, ELHAN ATİLLA HALİL, SOYKAN ARİF İRFAN, İDİLMAN RAMAZAN (2021). Clinical significance of concomitant extrahepatic autoimmune disease in patients with autoimmune liver disease. Hepatol Forum, 2(1), 3-6., Doi: 10.14744/hf.2020.2020.0028

   Source : page de profil sur medicana.com.tr

9. ÖZTÜRK KADİR, KURT ÖMER, ÇELEBİ GÜRKAN, ŞARLAK HAKAN, KARAKAYA MUHAMMED FATİH, DEMİRCİ HAKAN, KILINÇ ALİ, UYGUN AHMET (2020). High-dose dual therapy is effective as first-line treatment for Helicobacter pylori infection Turk J Gastroenterol., 31(3), 234-238., Doi: 10.5152/tjg.2020.18974

   Source : page de profil sur medicana.com.tr

10. Cox I. Jane, İDİLMAN RAMAZAN, Fagan Andrew, TURAN DİLARA, Ajayi Lola, Le Guennec Adrien D., Taylor-Robinson Simon D., KARAKAYA MUHAMMED FATİH, Gavis Edith, Atkinson R. Andrew, Williams Roger, Sikaroodi Masoumeh, Nizam Shahzor, Gillevet Patrick M., Bajaj Jasmohan S. (2019). Metabolomics and microbial composition increase insight into the impact of dietary differences in cirrhosis. Liver Int, 40(2), 416-427., Doi: 10.1111/liv.14256

    Source : page de profil sur medicana.com.tr